Inventor
David Joseph Guerin
Inventor
Natick, MA, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes18%
C07BGeneral methods of organic chemistry5%
Y02ATechnologies for adaptation to climate change5%
Y02PClimate change mitigation technologies in the production or processing of goods5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
PatentTitleYear
10,934,299Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors202110,913,753Thienopyridine carboxamides as ubiquitin-specific protease inhibitors202110,889,592Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors202110,377,760Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors201910,072,025Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors201810,059,705Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors20189,957,265N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors20189,957,264Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors20189,902,728'Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors'20189,884,048'ERK inhibitors'20189,725,445'Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors'20179,242,984'Pyrazolyl derivatives as Syk inhibitors'20169,023,865'Compounds that are ERK inhibitors'20158,937,077'Bicyclic diamines as janus kinase inhibitors'20158,551,984'Aminopyrimidines as SYK inhibitors'20138,329,722'Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1'20128,293,929'Processes and intermediates'20128,183,245'Pyrazine substituted pyrrolopyridines as inhibitors of JAK and PDK1'20127,834,200'Processes and intermediates'20107,550,478'Tyrosine kinase inhibitors'20097,381,827'Processes and intermediates'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2021Based in Natick, MA, US· patent location history
2012–2018Patents assigned to MERCK SHARP & DOHME (12)· patent assignee history
2012Patents assigned to GUERIN DAVID J (3)· patent assignee history
2013–2015Patents assigned to GUERIN DAVID JOSEPH (3)· patent assignee history
2018–2021Patents assigned to FORMA THERAPEUTICS INC (3)· patent assignee history
2021Patents assigned to VALO EARLY DISCOVERY INC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 12 | 2012–2018 |
| FORMA THERAPEUTICS INC | 3 | 2018–2021 |
| GUERIN DAVID Jself | 3 | 2012 |
| GUERIN DAVID JOSEPHself | 3 | 2013–2015 |
| VALO EARLY DISCOVERY INC | 3 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Natick, Massachusetts, US | 21 | 2008–2021 |